1356009-86-3

Upstream product

• 120-92-3 cyclopentanone 
• 1263868-30-9 2,4-dichloro-7-(4-fluorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine 
• 109-81-9 N-methyl-ethane-1,2-diamine 
• 352-13-6 4-flourophenylmagnesium bromide 
• 1263868-44-5 7-(4-fluorophenyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione 
• 1263868-43-4 7-(4-fluorophenyl)-6,7-dihydrocyclopenta[e][1,3]oxazine-2,4(3H,5H)-dione 
• 1014718-61-6 (±)-2-(4-fluorophenyl)cyclopentan-1-one 
• 827-57-6 1-cyclopent-1-enyl 4-fluorobenzene 

Downstream Products

• 1356010-39-3 4-amino-2-(2-((2-(2-chloro-7-(4-fluorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-ylamino)ethyl)(methyl)amino)ethoxy)benzonitrile 
• 1356010-54-2 N₁-(2-(5-amino-2-(3-methyl-1H-1,2,4-triazol-1-yl)phenoxy)ethyl)-N₂-(2-chloro-7-(4-fluorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)-N₁-methylethane-1,2-diamine 
• 1356007-28-7 (R)-7-cyano-19-(4-fluorophenyl)-12-methyl-11,12,13,14,15,17,18,19-octahydro-10H-16,2-(azeno)-8,4-(metheno)cyclopenta[i][1,4,7,11,13]oxatetraazacyclooctadecine 
• 1356007-30-1 (S)-7-cyano-19-(4-fluorophenyl)-12-methyl-11,12,13,14,15,17,18,19-octahydro-10H-16,2-(azeno)-8,4-(metheno)cyclopenta[i][1,4,7,11,13]oxatetraazacyclooctadecine 
• 1356009-85-2 N₁-(2-chloro-7-(4-fluorophenyl)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)-N₂-methyl-N₂-(2-(2-(3-methyl-1H-1,2,4-triazol-1-yl)-5-nitrophenoxy)ethyl)ethane-1,2-diamine 

Relevant academic research and scientific papers

COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION

Compounds of the formula (I) are provided, including pharmaceutically acceptable salts thereof: which modulate β-amyloid peptide (β-AP) production, and are useful in the treatment of Alzheimer's Disease and other conditions affected by -amyloid peptide (β-AP) production.